Sign in
KLRS Stock Price, Chart, Stats & News
Kalaris Therapeutics Inc
Save
82.48M
Market cap
–
Current P/E
–
Forward P/E
KLRS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -35.68% |
ROE | -73.11% |
D/E | 0.02x |
Interest coverage ratio | -31.98x |
KLRS valuation
P/E | – |
P/S | – |
P/B | 1.57x |
P/CF | -2.87x |
P/FCF | -2.33x |
P/OCF | -2.87x |
PEG | -0.07x |
EV multiple | -4.61x |
About
Kalaris Therapeutics Inc. operates as a pharmaceutical enterprise. The company's core mission centers on developing innovative cell therapies. These treatments are designed to reactivate the body's inherent immunity against critical, virus-linked diseases, especially in patients with profoundly compromised immune systems.
Similar securities
Based on sector and market capitalization
Report issue